Ocrelizumab in Multiple Sclerosis: A Real-World Study From Spain

Objectives: The aim of this study was to describe the tolerability, safety, and effectiveness of ocrelizumab for primary progressive multiple sclerosis (PPMS) and relapsing multiple sclerosis (RMS) in a clinical practice setting. Methods: In this retrospective observational study, we analyzed clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Sempere, Angel P., Berenguer-Ruiz, Leticia, Borrego-Soriano, Ines, Burgos-San Jose, Amparo, Concepcion-Aramendia, Luis, Volar, Lucian, Aragones, Miguel, Palazón-Bru, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844090/
https://www.ncbi.nlm.nih.gov/pubmed/33519676
http://dx.doi.org/10.3389/fneur.2020.592304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844090/
https://www.ncbi.nlm.nih.gov/pubmed/33519676
http://dx.doi.org/10.3389/fneur.2020.592304

Ejemplares similares